Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Adult-Onset Still's Disease
Interventions
DRUG

anakinra

100 mg subcutaneous injection daily

DRUG

comparators

po drugs, comparators

Trial Locations (1)

75185

Ann Kataja Knight, Uppsala

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

Tampere University Hospital

OTHER

collaborator

Turku University Hospital

OTHER_GOV

collaborator

Oulu University Hospital

OTHER

collaborator

Kuopio University Hospital

OTHER

collaborator

Jyväskylä Central Hospital

OTHER

collaborator

Satakunta Central Hospital

OTHER

collaborator

University Hospital, Umeå

OTHER

collaborator

University Hospital, Linkoeping

OTHER

lead

University of Helsinki

OTHER

NCT01033656 - Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study | Biotech Hunter | Biotech Hunter